NYSE ARCA | ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities.
The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| QNTM | Quantum BioPharma Ltd. | Healthcare | Biotechnology | 11.72% |
| ATAI | ATAI Life Sciences BV | Healthcare | Biotechnology | 8.41% |
| CYBN | Cybin Inc | Healthcare | Biotechnology | 7.94% |
| NRXP | NRX Pharmaceuticals Inc | Healthcare | Biotechnology | 7.70% |
| MNMD | Mind Medicine Inc | Healthcare | Biotechnology | 7.66% |
| CYBN | Cybin Inc | Healthcare | Biotechnology | 7.55% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 6.90% |
| CMPS | Compass Pathways Plc | Healthcare | Medical Care Facilities | 5.57% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 5.29% |
| TTTXX | BlackRock Liquidity Funds - Treasury Trust Fund | 5.27% | ||
| QNTM | Quantum BioPharma Ltd Ordinary Shares - Class B (Sub Voting) | 5.20% | ||
| STIM | Neuronetics Inc | Healthcare | Medical Devices | 4.75% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.65% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.22% |
| GHRS | GH Research PLC | Healthcare | Biotechnology | 4.20% |
| NEUP | Neuphoria Therapeutics Inc | Healthcare | Biotechnology | 4.19% |
| RLMD | Relmada Therapeutics Inc | Healthcare | Biotechnology | 2.38% |
| SLZA | ENVERIC BIOSCI.INC.DL-01 | Healthcare | Biotechnology | 1.97% |
| CMND | Clearmind Medicine Inc. Common Shares | Healthcare | Biotechnology | 1.59% |
| SILO | Silo Pharma Inc | Healthcare | Biotechnology | 0.97% |